Diabetes, kidney disease and anaemia: time to tackle a troublesome triad?
- 29 January 2007
- journal article
- review article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 61 (2) , 281-289
Abstract
Both chronic kidney disease (CKD) and type II diabetes mellitus (DM) are increasing in frequency among Western populations and both are potent risk factors for the development of anaemia. The presence of CKD and diabetes together represent the most important aetiopathogenic combination for the development of anaemia. New evidence has highlighted some of the underlying mechanisms which make diabetic patients more susceptible to dyserythropoiesis, particularly once they have developed concomitant CKD. In addition, recent publications from large‐scale epidemiological studies have highlighted the impact of anaemia on diabetic patients. The purpose of this review was to focus on the pathophysiology and impact of anaemia in DM.Keywords
This publication has 69 references indexed in Scilit:
- Erythropoietin attenuated high glucose-induced apoptosis in cultured human aortic endothelial cellsBiochemical and Biophysical Research Communications, 2005
- Erythropoietin receptors: their role beyond erythropoiesisNephrology Dialysis Transplantation, 2005
- Coronary artery, aortic wall, and valvular calcification in nondialyzed individuals with type 2 diabetes and renal diseaseKidney International, 2003
- RosiglitazoneDrugs, 2002
- Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patientsNephrology Dialysis Transplantation, 2001
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997
- Analysis of Heart Morphology and Function Following Erythropoietin Treatment of Anemic Dialysis PatientsArtificial Organs, 1993
- Vascular changes in hemodialysis patients in response to recombinant human erythropoietinKidney International, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Effects of long-term blockade of angiotensin converting enzyme with captopril (SQ14,225) on hemodynamics and circulating blood volume in SHR.Hypertension, 1980